5-HT1A Agonist Properties Contribute to a Robust Response to Vilazodone in the Novelty Suppressed Feeding Paradigm

scientific article

5-HT1A Agonist Properties Contribute to a Robust Response to Vilazodone in the Novelty Suppressed Feeding Paradigm is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/IJNP/PYW057
P932PMC publication ID5091830
P698PubMed publication ID27352617

P50authorEduardo LeonardoQ71663560
P2093author name stringAlex Dranovsky
Alvaro L Garcia-Garcia
Míriam Navarro-Sobrino
Gila Pilosof
Pradeep Banerjee
P2860cites workRole of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.Q48294709
Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions.Q48432408
Gepirone Extended-Release in the Treatment of Adult Outpatients With Major Depressive DisorderQ56431859
A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatientsQ71878226
Contribution of spinal 5-HT1A and 5-HT7 receptors to locomotor-like movement induced by 8-OH-DPAT in spinal cord-transected miceQ79889518
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010Q27860791
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressantsQ29547516
Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorderQ33792011
The therapeutic role of 5-HT1A and 5-HT2A receptors in depressionQ34340909
Gepirone extended-release in the treatment of adult outpatients with major depressive disorder: a double-blind, randomized, placebo-controlled, parallel-group studyQ34765251
Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxietyQ35008700
Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia testQ36125183
Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm.Q37141553
Transcriptional regulation at a HTR1A polymorphism associated with mental illness.Q37221214
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.Q37380865
5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressantsQ39281683
The effects of chronic antidepressant treatment in an animal model of anxietyQ42209089
Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitorQ42441739
Sensitivity to the effects of pharmacologically selective antidepressants in different strains of miceQ43658274
Effects of chronic fluoxetine in animal models of anxiety and depression.Q44845253
Multifaceted strain-specific effects in a mouse model of depression and of antidepressant reversalQ46368779
Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells.Q46767739
P433issue10
P407language of work or nameEnglishQ1860
P577publication date2016-06-28
P1433published inThe International Journal of NeuropsychopharmacologyQ7742309
P1476title5-HT1A Agonist Properties Contribute to a Robust Response to Vilazodone in the Novelty Suppressed Feeding Paradigm
P478volume19

Search more.